Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Assessment of Compl-AI in Predicting Early Discontinuation of Medication for Treatment of Opioid Use Disorder (MOUD) in Community and Specialty Treatment Programs

NCT07456930 is registered in ClinicalTrials.gov with Tools4Patient as lead sponsor.

NCT NCT07456930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07456930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Assessment of Compl-AI in Predicting Early Discontinuation of Medication for Treatment of Opioid Use Disorder (MOUD) in Community and Specialty Treatment Programs
Lead sponsor
Tools4Patient
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2027
Completion date
December 31, 2027
Enrollment
295 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder